Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy

ClinicalTrials.gov ID: NCT02914314

Public ClinicalTrials.gov record NCT02914314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 2:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 4 Years of Age With Epilepsy

Study identification

NCT ID
NCT02914314
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
26 participants

Conditions and interventions

Conditions

Interventions

  • perampanel Drug

Drug

Eligibility (public fields only)

Age range
1 Month to 4 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 19, 2017
Primary completion
Aug 22, 2022
Completion
Apr 24, 2023
Last update posted
Mar 14, 2024

2017 – 2023

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027
David Geffen School of Medicine at UCLA Los Angeles California 90095-1752
NW FL Clinical Research Group, LL-ClinEdge- PPDS Gulf Breeze Florida 32561
Axcess Medical Research Loxahatchee Groves Florida 33470
Pediatric Neurology PA Orlando Florida 32819
Pediatric Epilepsy And Neurology Specialists Tampa Florida 33609
Children's Healthcare of Atlanta Atlanta Georgia 30329
Augusta University Augusta Georgia 30912
Carle Foundation Hospital Urbana Illinois 61801
University of Kentucky Lexington Kentucky 40536-0284
Children's Mercy Hospital Kansas City Missouri 64108-4619
Children's Hospital at Saint Peter's University Hospital New Brunswick New Jersey 08901
Duke University Medical Center, Children's Health Center Durham North Carolina 27710
Atrium Health Wake Forest Baptist Medical Center PPDS Winston-Salem North Carolina 27157
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Child Neurology Consultants of Austin Austin Texas 78749
Road Runner Research, Ltd San Antonio Texas 78249

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02914314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 14, 2024 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02914314 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →